Evidence map›Paper›PMID 26846164›Full record

ReviewWiley interdisciplinary reviews. Nanomedicine and nanobiotechnology2016

Label-free detection and manipulation of single biological nanoparticles.

Michael C DeSantis, Wei Cheng

Open access · greenAbstract readReview
In one paragraph

Review in Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Michael C DeSantisDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, MI, USA.
Wei ChengDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, MI, USA.
University of Michigan–Ann Arbor · US

Funding

Single Cell with One Particle Entry (SCOPE) for Study of HIV InfectionDP2OD008693 · OD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHENG, WEI · 2011 to 2012
$2.5M
Coupled Interactions Limiting HIV-1 Infection Verified by Single Molecule StudiesF32GM109771 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DESANTIS, MICHAEL · 2014 to 2015
$106k
NIGMS NIH HHS F32 GM109771NIH HHS DP2 OD008693
6 · The paper itself

Abstract

In the past several years, there have been significant advances in the field of nanoparticle detection for various biological applications. Of considerable interest are synthetic nanoparticles being designed as potential drug delivery systems as well as naturally occurring or biological nanoparticles, including viruses and extracellular vesicles. Many infectious diseases and several human cancers are attributed to individual virions. Because these particles likely display different degrees of heterogeneity under normal physiological conditions, characterization of these natural nanoparticles with single-particle sensitivity is necessary for elucidating information on their basic structure and function as well as revealing novel targets for therapeutic intervention. Additionally, biodefense and point-of-care clinical testing demand ultrasensitive detection of viral pathogens particularly with high specificity. Consequently, the ability to perform label-free virus sensing has motivated the development of multiple electrical-, mechanical-, and optical-based detection techniques, some of which may even have the potential for nanoparticle sorting and multi-parametric analysis. For each technique, the challenges associated with label-free detection and measurement sensitivity are discussed as are their potential contributions for future real-world applications. WIREs Nanomed Nanobiotechnol 2016, 8:717-729. doi: 10.1002/wnan.1392 For further resources related to this article, please visit the WIREs website.

Indexed as

DNA, ViralMicrofluidic Analytical TechniquesNanomedicineVirionHumansNanoparticlesVirus DiseasesDNA, Viral

Identifiers

PMID26846164
PMCPMC5538576
OpenAlexW2256355146

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.